Imaging and percutaneous treatment of vascular anomalies

Seminars in Interventional Radiology

Volumn 25, Issue 3, 2008, Pages 216-233

  Vaidya, Sandeep ^a   Cooke, Danie ^a   Kogut, Matthew ^a   Stratil, Peter G ^a   Bittles, Mark A ^b   Sidhu, Manrita S ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Embolization; Hemangiomas; Malformations; Percutaneous endovascular therapy; Vascular anomalies

Indexed keywords

EID: 62249106694     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0028-1085921     Document Type: Article

References (124)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based ,on endothelial characteristics. Plast Reconstr Surg 1982; 69(3):412-422
2. JK W, TS L, CT R, et al. For hemangiomas refractory to first line corticosteroid therapy, interferon and vincristine therapy has been described. In, International Society for the Study of Vascular Anomalies. Wellington, New Zealand; 2004
3. Chang MW. Updated classification of hemangiomas and other vascular anomalies. Lymphat Res Biol 2003;1(4):259-265
4. Upton J, Coombs CJ, Mulliken JB, Burrows PE, Pap S. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg [Am] 1999;24(5):1019-1035
5. Cho SK, Do YS, Shin SW, Kim DI, et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther 2006; 13:527-538
6. Jacobowitz G, Rosen RJ, Rockman CB, et al. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up. J Vasc Surg 2001;33(1): 51-55
7. Hadizadeh DR, von Falkenhausen M, Gieseke J, et al. Cerebral arteriovenous malformation: Spetzler-Martin classification at subsecond-temporal-resolution four-dimensional MR angiography compared with that at DSA. Radiology 2008;246(1):205-213
8. Bittles MA, Sidhu MK, Sze RW, et al. Multidetector CT angiography of pediatric vascular malformations and hemangiomas: utility of 3-D reformatting in differential diagnosis. Pediatr Radiol 2005;35(11):1100-1106
9. Ohgiya Y, Hashimoto T, Gokan T. Dynamic MRI for Distinguishing High-flow from Low-flow peripheral vascular malformations. AJR Am J Roentgenol 2005;185(5): 1131-1137
10. Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004;39(3):590-600
11. Do YS, Yakes WF, Shin SW, et al. ethanol embolization of arteriovenous malformations: interim results. Radiology 2005;235(2):674-682
12. Jordan O, Doelker E, Rufenacht DA. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces. Cardiovasc Intervent Radiol 2005;28(5): 561-569
13. Osuga K, Hori S, Kitayoshi H, et al. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol 2002;13(11):1125-1133
14. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 1989;170(3 Pt 2):1059-1066
15. White RI Jr, Pollak J, Persing J, et al. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations. J Vasc Interv Radiol 2000; 11(10):1285-1295
16. Vikkula M, Boon L, Mulliken J. Molecular genetics of vascular malformations. Matrix Biol 2001;20(5-6):327-335
17. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15(5): 431-445
18. Claudon M, Upton J, Burrows P. Diffuse venous malformations of the upper limb: morphologic characterization by ,MRI and venography. Pediatr Radiol 2001;31(7):507-514
19. Ohlms LA, Forsen J, Burrows PE. Venous malformation of the pediatric airway. Int J Pediatr Otorhinolaryngol 1996; 37(2):99-114
20. Mason KP, Neufeld EJ, Karian VE, et al. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol 2001;177(6):1359-1363
21. van Rijswijk CS, van der Linden E, van der Woude HJ, van Baalen JM, Bloem JL. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol 2002; 178(5):1181-1187
22. Dobson MJ, Hartley RW, Ashleigh R, Watson Y, Hawnaur JM. MR angiography and MR imaging of symptomatic vascular malformations. Clin Radiol 1997;52(8):595-602
23. Kim EY, Ahn JM, Yoon HK, et al. Intramuscular vascular malformations of an extremity: findings on MR imaging and pathologic correlation. Skeletal Radiol 1999;28(9):515-521
24. Herborn CU, Goyen M, Lauenstein TC, et al. Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol 2003;181(3):729-735
25. Rak KM, Yakes WF, Ray RL, et al. MR imaging of symptomatic peripheral vascular malformations. AJR Am J Roentgenol 1992;159(1):107-112
26. Meyer JS, Hoffer FA, Barnes PD, Mulliken JB. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol 1991;157(3):559-564
27. Buchta K, Sands J, Rosenkrantz H, Roche W. Early, mechanism of action of arterially infused alcohol U.S.P. in renal devitalization. Radiology 1982;145(1):45-48
28. Anadon MJ, Almendral J, Gonza'lez P, et al. Alcohol concentration determines the type of atrial arrhythmia induced in a porcine model of acute alcoholic intoxication.Pacing Clin Electrophysiol 1996;19(11 Pt 2):1962-1967
29. Chi LM, Wu WG. Mechanism of hemolysis of red blood cell mediated by ethanol. Biochim Biophys Acta 1991;1062(1):46-50
30. Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg 1995;80(2):415-417
31. Berenguer B, Burrows P, Zurakowski D, Mulliken J. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104(1):1-11; discussion 12-15
32. Lee BB, Do YS, Byun HS, et al. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003;37(3):533-538
33. Mitchell SE, Shah AM, Schwengel D. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted? J Vasc Interv Radiol 2006;17(2 Pt 1):253-262
34. Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg 1997;31(2):145-150
35. de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg 1995;30(2):188-193; discussion 194
36. Cabrera J, Cabrera JJ, Garcia-Olmedo M. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001; 20(4):322-329
37. Sidhu MK, Perkins JA, Shaw DW, Bittles MA, Andrews RT. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol 2005;16(6):879-884
38. van der Linden E, Overbosch J, Kroft L. Radiofrequency ablation for treatment of symptomatic low-flow vascul malformations after previous unsuccessful therapy. J Vasc Interv Radiol 2005;16(5):747-750
39. Belov S. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg 1993;6(4):219-224
40. Lee BB, Kim YW, Seo JM, et al. Current concepts in lymphatic malformation. Vasc Endovascular Surg 2005; 39(1):67-81
41. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000;37(8):517-584
42. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement.J Vasc Interv Radiol 2006;17(10):1639-1648
43. Sanlialp I, Karnak I, Tanyel F, Senocak M, Büyükpamukçu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003;67(7):795-800
44. Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997;204(3): 651-654
45. Ogita S, Tsuto T, Deguchi E, et al. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 1991;26(3):263-268; discussion 268-270
46. Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol 2002;259(5): 274-278
47. Molitch HI, Unger EC, Witte CL, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas. Radiology 1995;194(2):343-347
48. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995;30(9):1282-1287
49. Shiels WE 2nd, Kenney B, Caniano D, Besner G. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg 2008; 43(1):136-139; discussion 140
50. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic mimaging in the evaluation of vascular birthmarks. Dermatol Clin 1998;16(3):455-488
51. Fishman SJ, Mulliken JB. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am 1993;40(6):1177-1200
52. Hemangioma Investigator GroupHaggstrom AN, Drolet BA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150(3):291-294
53. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005;22(5):383-406
54. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118(3):882-887
55. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326(22):1456-1463
56. Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg 1998;33(7):1163-1167
57. Achauer BM, Chang CJ, Vander Kam VM.Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg 1997;99(5):1301-1308
58. Laor T, Jaramillo D, Hoffer F, Kasser J. MR imaging in congenital lower limb deformities. Pediatr Radiol 1996; 26(6):381-387
59. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997;130(4):631-640
60. Berenguer B, Mulliken J, Enjolras O, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003;6(6):495-510
61. Enjolras O, Mulliken J, Boon L, et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001;107(7):1647-1654
62. Donnelly LF, Adams DM, Bisset GS. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 2000;174(3):597-608
63. Dubois J, Patriquin H, Garel L, et al. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol 1998;171(1):247-252
64. Hovius SE, Borg DH, Paans PR, Pieterman H. The diagnostic value of magnetic resonance imaging in combination with angiography in patients with vascular malformations: a prospective study. Ann Plast Surg 1996;37(3):278-285
65. Kern S, Niemeyer C, Darge K, et al. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations. Acta Radiol 2000;41(5):453-457
66. Konez O, Burrows P, Mulliken J, Fishman S, Kozakewich H. Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol 2003;33(1):15-19
67. Laor T, Burrows P. Congenital anomalies and vascular birthmarks of the lower extremities. Magn Reson Imaging Clin N Am 1998;6(3):497-519
68. Chamlin S, Haggstrom A, Drolet B, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007;151(6):684-689
69. Amir J, Metzker A, Krikler R, Reisner S. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3(4):331-332
70. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58(2):218-222
71. Boye E, Yu Y, Paranya G, et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001;107(6):745-752
72. Walter JW, North PE, Waner M, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002;33(3): 295-303
73. North PE, Waner M, Mizeracki A, Mihm MC. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31(1):11-22
74. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137(5):559-570 75. Yu Y, Flint A, Mulliken J, Wu J, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood 2004;103(4): 1373-1375
75. Dubois J, Milot J, Jaeger B, et al. Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems? J Am Acad Dermatol 2006;55(4):614-619
76. Haik BG, Jakobiec FA, Ellsworth RM, Jones IS. Capillary hemangioma of the lids and orbit: an analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology 1979;86(5):760-792
77. Stigmar G, Crawford J, Ward C, Thomson H. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit. Am J Ophthalmol 1978;85(6):806-813
78. Enjolras O, Riche M, Merland J, Escande J. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85(4):491-498
79. Rahbar R, Nicollas R, Roger G, et al. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope 2004;114(11):1880- 1891
80. Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg 2005;132(2): 226-231
81. Christison-Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007;42(1):62-67; discussion 67-68
82. Burrows PE, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol 2001;31(8):533-545
83. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996;129(3):346-354
84. Kassarjian A, Dubois J, Burrows PE. Angiographic classification of hepatic hemangiomas in infants. Radiology 2002;222(3):693-698
85. Kassarjian A, Zurakowski D, Dubois J, et al. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 2004; 182(3):785-795
86. Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989;83(6):977-980
87. Burke DR, Verstandig A, Edwards O, et al. Infantile hemangioendothelioma: angiographic features and factors determining efficacy of hepatic artery embolization. Cardiovasc Intervent Radiol 1986;9(3):154-157
88. Fishman SJ, Mulliken JB. Vascular anomalies. A primer for pediatricians. Pediatr Clin North Am 1998;45(6):1455-1477
89. Pope E, Krafchik B, Macarthur C, et al. Oral versus highdose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007; 119(6):e1239-e1247
90. Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol 2000;29(6):361-366
91. Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 1996;128(1):141-146
92. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999;104(6):1616-1623
93. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140(8): 963-969
94. Kushner BJ. The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast Reconstr Surg 1985;76(4):517-526
95. Sloan GM, Reinisch JF, Nichter LS, et al. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg 1989;83(3):459-467
96. Greinwald JH, Burke DK, Bonthius DJ, Bauman NM, Smith RJ. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999;125(1):21-27
97. Enjolras O, Brevie're GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004;11(2):99-107
98. Perez J, Pardo J, Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 2002;41(2):197-199
99. Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57(2): 168-171
100. David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg 2003;56(4):317-327
101. Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol 2000; 143(2):356-359
102. Poetke M, Philipp C, Berlien H. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol 2000;136(5):628-632
103. Waner M, Suen J, Dinehart S, Mallory S. Laser photocoagulation of superficial proliferating hemangiomas. J Dermatol Surg Oncol 1994;20(1):43-46
104. Batta K, Goodyear H, Moss C, et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 2002;360(9332):521-527
105. Burrows PE, Rosenberg H, Chuang H. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. Radiology 1985;156(1): 85-88
106. Johnson DH, Vinson AM,Wirth FH, et al.Management of hepatic hemangioendotheliomas of infancy by transarterial embolization: a report of two cases. Pediatrics 1984;73(4): 546-549
107. Warmann S, Bertram H, Kardorff R, et al. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg 2003;38(8):1177-1181
108. Holcomb GW 3rd, O'Neill JA Jr, Mahboubi S, Bishop HC. Experience with hepatic hemangioendothelioma in infancy and childhood. J Pediatr Surg 1988;23(7):661-666
109. Stanley P, Grinnell V, Stanton R, Williams K, Shore N. Therapeutic embolization of infantile hepatic hemangioma with polyvinyl alcohol. AJR Am J Roentgenol 1983; 141(5):1047-1051
110. Jianhong L, Xianliang H, Xuewu J. Transcatheter arterial embolization in the treatment of extensive maxillofacial hemangioma in children. World J Surg 2005;29(12):1550-1556
111. Andronikou S, Mandelstam S, Fasulakis S. MRI and preoperative embolization of a nasal cavity haemangioma in a child. Australas Radiol 2003;47(4):386-388 232
112. Konior RJ, Holinger LD, Russell EJ. Superselective embolization of laryngeal hemangioma. Laryngoscope 1988; 98(8 Pt 1):830-834
113. Burrows PE, Lasjaunias P, Ter Brugge K, Flodmark O. Urgent and emergent embolization of lesions of the head and neck in children: indications and results. Pediatrics 1987;80(3):386-394
114. Kaneko R, Tohnai I, Ueda M, et al. Curative treatment of central hemangioma in the mandible by direct puncture and embolisation with n-butyl-cyanoacrylate (NBCA). Oral Oncol 2001;37(7):605-608
115. O'Donovan JC, Donaldson JS, Morello FP, et al. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 1997;169(3):723-729
116. Hayashi N, Masumoto T, Okubo T, et al. Hemangiomas in the face and extremities: MR-guided sclerotherapy-optimization with monitoring of signal intensity changes in vivo. Radiology 2003;226(2):567-572
117. Winter H, Dräger E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg 2000;26(2):105-108
118. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17(4):321-328
119. Lyons LL, North PE, Mac-Moune Lai F, et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28(5): 559-568
120. Enjolras O, Mulliken J, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000;42(2 Pt 1):225-235
121. Gruman A, Liang M, Mulliken J, et al. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol 2005;52(4):616-622
122. Hauer J, Graubner U, Konstantopoulos N, et al. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer 2007;49(6):852-854
123. Harper L, Michel J, Enjolras O, et al. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alphainterferon. Eur J Pediatr Surg 2006;16(5):369-372
124. Haisley-Royster C, Enjolras O, Frieden I, et al. Kasabachmerritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002;24(6): 459-462